Ondansetron Strandhaven T/A Somex Pharma

Ondansetron, the active ingredient in Ondansetron Strandhaven T/A Somex Pharma, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiotherapy and postoperative recovery in adult and pediatric patients. GNH USA supplies Ondansetron Strandhaven T/A Somex Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Ondansetron Strandhaven T/A Somex Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Ondansetron is used to manage nausea and vomiting associated with several clinical pathways: - Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiotherapy‑induced nausea and vomiting: helps control nausea during and after radiation treatment. - Post‑operative nausea and vomiting: prevents vomiting in the immediate postoperative period. - Pregnancy‑related hyperemesis gravidarum (off‑label in some regions): may be considered when conventional therapy fails.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel movement difficulty. - Diarrhoea: loose stools may occur. - Fatigue: feeling of tiredness. - Dizziness: transient light‑headedness. - Injection site pain (if administered parenterally).

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation, especially with IV use. - Severe hypersensitivity: rash, itching, swelling, or anaphylaxis. - Serotonin syndrome: rare when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes. - Neuroleptic malignant‑like reactions: very rare neurological events.

Precautions should be observed when prescribing ondansetron: - Cardiac monitoring: assess baseline ECG in patients with known cardiac disease. - Electrolyte balance: correct hypokalaemia or hypomagnesaemia before use. - Drug interactions: review concomitant medications that may affect QT interval. - Pregnancy: use only if benefits outweigh potential risks. - Lactation: consider infant exposure through breast milk. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ondansetron may interact with several medicines: Major Interactions (Avoid): - Amiodarone: increased risk of QT prolongation and arrhythmia. - Cisapride: additive effect on QT interval prolongation. - Certain anti‑malarial drugs (e.g., quinidine): heightened arrhythmic risk.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): potential for serotonin syndrome. - Antifungal azoles (ketoconazole, fluconazole): may increase ondansetron plasma levels. - Macrolide antibiotics (erythromycin): modest QT‑prolonging effect. - Calcium channel blockers (dizzy ).